Table 1.
Clinicopathological characteristics of uterine corpus endometrial carcinoma (UCEC) patients with differential RPP40 expression.
| Characteristic | Low-RPP40 expression (N = 276) | High-RPP40 expression (N = 276) | P-value |
|---|---|---|---|
| Clinical stage, n (%) | 0.038 | ||
| Stage I | 185 (33.5%) | 157 (28.4%) | |
| Stage II | 25 (4.5%) | 26 (4.7%) | |
| Stage III | 57 (10.3%) | 73 (13.2%) | |
| Stage IV | 9 (1.6%) | 20 (3.6%) | |
| Primary therapy outcome, n (%) | < 0.001 | ||
| PD | 8 (1.7%) | 12 (2.5%) | |
| SD | 3 (0.6%) | 3 (0.6%) | |
| PR | 0 (0%) | 12 (2.5%) | |
| CR | 238 (49.6%) | 204 (42.5%) | |
| Race, n (%) | 0.176 | ||
| Asian | 11 (2.2%) | 9 (1.8%) | |
| Black or African American | 45 (8.9%) | 63 (12.4%) | |
| White | 195 (38.5%) | 184 (36.3%) | |
| Age, n (%) | 0.088 | ||
| <=60 | 113 (20.6%) | 93 (16.9%) | |
| >60 | 161 (29.3%) | 182 (33.2%) | |
| BMI, n (%) | 0.179 | ||
| <=30 | 99 (19.1%) | 113 (21.8%) | |
| >30 | 163 (31.4%) | 144 (27.7%) | |
| Histological type, n (%) | < 0.001 | ||
| Endometrioid | 234 (42.4%) | 176 (31.9%) | |
| Mixed | 11 (2%) | 13 (2.4%) | |
| Serous | 31 (5.6%) | 87 (15.8%) | |
| Residual tumor, n (%) | 0.857 | ||
| R0 | 193 (46.7%) | 182 (44.1%) | |
| R1 | 10 (2.4%) | 12 (2.9%) | |
| R2 | 8 (1.9%) | 8 (1.9%) | |
| Histologic grade, n (%) | < 0.001 | ||
| G1 | 74 (13.7%) | 24 (4.4%) | |
| G2 | 73 (13.5%) | 47 (8.7%) | |
| G3 | 125 (23.1%) | 198 (36.6%) | |
| Tumor invasion (%), n (%) | 0.697 | ||
| <50 | 134 (28.3%) | 125 (26.4%) | |
| >=50 | 116 (24.5%) | 99 (20.9%) | |
| Menopause status, n (%) | 0.500 | ||
| Pre | 20 (4%) | 15 (3%) | |
| Peri | 10 (2%) | 7 (1.4%) | |
| Post | 223 (44.1%) | 231 (45.7%) | |
| Hormones therapy, n (%) | 0.416 | ||
| No | 148 (43%) | 149 (43.3%) | |
| Yes | 27 (7.8%) | 20 (5.8%) | |
| Diabetes, n (%) | 0.403 | ||
| No | 171 (37.9%) | 157 (34.8%) | |
| Yes | 58 (12.9%) | 65 (14.4%) | |
| Radiation therapy, n (%) | 0.980 | ||
| No | 142 (26.9%) | 137 (26%) | |
| Yes | 125 (23.7%) | 123 (23.3%) | |
| Surgical approach, n (%) | 0.874 | ||
| Minimally invasive | 103 (19.4%) | 105 (19.8%) | |
| Open | 163 (30.8%) | 159 (30%) | |
| OS event, n (%) | < 0.001 | ||
| Alive | 246 (44.6%) | 212 (38.4%) | |
| Dead | 30 (5.4%) | 64 (11.6%) | |
| DSS event, n (%) | 0.003 | ||
| Alive | 256 (46.5%) | 231 (42%) | |
| Dead | 20 (3.6%) | 43 (7.8%) | |
| PFI event, n (%) | 0.005 | ||
| Alive | 226 (40.9%) | 197 (35.7%) | |
| Dead | 50 (9.1%) | 79 (14.3%) |